Kaiser Permanente and University of Michigan receive $10.5 million to advance AI tools for cardiovascular disease screening and emergency response.
Key Details
- 1American Heart Association awarded $10.5M to two research teams for AI projects in cardiovascular care.
- 2Kaiser Permanente's project will use AI to detect kidney and liver disease on echocardiograms and conduct a multi-center clinical trial.
- 3University of Michigan's project will develop AI-guided wearable sensors for improved CPR outcomes.
- 4Cardiovascular disease caused 19.41 million global deaths in 2021; over 400,000 cardiac arrest deaths occur yearly in the U.S.
- 5AI aims to improve health professional decision making and treatment effectiveness for leading causes of death.
Why It Matters
These grants support pioneering research integrating AI with medical imaging and sensing to enable earlier disease detection and more personalized emergency care. The projects have potential to transform outcomes for cardiovascular, kidney, and liver conditions, which together cause millions of deaths globally.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.